DEAD‐box helicase 1 inhibited CD8+ T cell antitumor activity by inducing PD‐L1 expression in hepatocellular carcinoma

Documenti analoghi

• Intratumoral administration of poly‐ICLC enhances the antitumor effects of anti‐PD‐1
  di: Shin‐Yun Liu, et al.
  Pubblicazione: (2024)
• The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma
  di: Shuwen Kuang, et al.
  Pubblicazione: (2024)
• HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBC
  di: Bo Luo, et al.
  Pubblicazione: (2024)
• Diverse functions of DEAD ‐box proteins in oligodendrocyte development, differentiation, and homeostasis
  di: Norihisa Bizen, et al.
  Pubblicazione: (2024)
• A Novel Predictor of the Length and Size of ACL Grafts in Chinese Han Adults for ACL Reconstruction: An MRI Study
  di: Qingjun Yang, et al.
  Pubblicazione: (2024)